SHSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/12/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSHSE
Market Capitalization6,764.89 mln
Float212 mln
EPS
0.01
Overpriced
P / E
1,834
Bubble territory
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-1.91
Caution advised
Relative Strength
22
/ 100
Significantly lagging
Debt / Equity
0.43
Low leverage
Business Description
Founded in 2002 and based in Nanjing, China, Frontier Biotechnologies Inc. is a fully operational biopharmaceutical company that researches, produces, and sells medicines aimed at improving patient health. Its flagship product, Aikening, is an established treatment for HIV and AIDS, while its growing pipeline targets a range of serious conditions including kidney disease, high cholesterol, gout, bone loss, and liver disease. The company is also advancing treatments for pain affecting muscles, bones, and joints, reflecting its broad commitment to addressing unmet medical needs across multiple therapeutic areas.
